Ipsen (United States)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
56%
Total
Publications
357
Total Open
Publications
200
Total
Citations
5.4K
Open Access
Percentage
56%
Total
Publications
357
Total Open
Publications
200
Total
Citations
5.4K
Breakdown
Publisher Open
26%
Both
28%
Other Platform Open
2%
Closed
44%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
47
Hybrid 62%
118
No Guarantees 14%
26
Other Platform Open
Domain 77%
84
Institution 29%
32
Other Internet 17%
19
Public 4%
4
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 85 |
Unknown Repository | Other Internet | 11 |
DOI | Other Internet | 9 |
Europe PMC | Domain | 7 |
Academy of Humanities and Economics in Lodz - Homo Politicus | Institution | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |
Elsevier - Scopus | Institution | 4 |
Digital Access to Libraries | Institution | 4 |
Figshare | Public | 3 |
Utrecht University - Utrecht University Repository | Institution | 2 |